news.today
Hello · Register today | LoginHello · My Account[—] [33]
Tech

New drug halves cognitive decline rate in Alzheimer's trial

Summarised from 2 outlets · Updated 19 Nov, 17:50 · Archive

Patients given diranersen injections showed 54 per cent less cognitive decline over two years in a major trial.

Patients given low-dose diranersen injections showed 54 per cent less decline on a test of memory and thinking over almost two years, according to trial results announced at the Clinical Trials on Alzheimer's Disease conference in Boston. The drug is administered twice a year via lumbar puncture into the fluid around the spinal cord. It uses gene-silencing technology to target tau at its source, blocking the RNA messages that signal for brain cells to produce tau rather than attempting to clear the protein once it has built up.

Alzheimer's disease is thought to be caused by a build-up of proteins, including amyloid and tau, in the brain, which affect how brain cells transmit messages. As time passes, more brain cells are damaged, leading to worsening symptoms. There is currently no cure to stop or reverse the disease.

Professor Reisa Sperling, a co-author of the study and professor of neurology at Harvard Medical School, described the results as 'thrilling'. 'These data suggest that we're not just slowing the accumulation of tau, but we are lowering aggregated tau from baseline,' she said. Professor Jeffrey Cummings, also a co-author, told the conference: 'We reversed Alzheimer pathology. We removed tau tangles. That's a remarkable statement.' Priya Singhal, executive vice president and head of development at Biogen, which developed the drug, said the results 'strengthen the growing body of evidence supporting tau as a therapeutic target'.

New drug halves cognitive decline rate in Alzheimer's trial
Image: New York Post

Comments (0)

How it is being reported

In this story: Biogen · Harvard Medical School · Reisa Sperling · Jeffrey Cummings · Boston

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log